Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002115766 | SCV002405124 | benign | not provided | 2024-12-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002115766 | SCV004184173 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | DNAJB13: BP4, BS2 |
Breakthrough Genomics, |
RCV002115766 | SCV005232231 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003958733 | SCV004774041 | likely benign | DNAJB13-related disorder | 2019-11-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |